Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.
Clinical trial NCT01991899 · COMPLETED
Trial details
- NCT number
- NCT01991899
- Sponsor
- The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2015-12-01
- Enrollment
- 1560
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.